Psychosis is a common and distressing symptom in people with Alzheimer disease, and few
safe and effective treatments are available. However, new approaches to symptom …

Introduction Despite the urgent need for remote neurobehavioral assessment of individuals
with cognitive impairment, guidance is lacking. Our goal is to provide a multi‐dimensional …

Mild behavioral impairment (MBI) is suggested as risk marker for neurodegenerative
diseases, such as Alzheimer's disease (AD). Recently, pathologic tau deposition in the brain …

Objectives Mild behavioral impairment (MBI) is a syndrome describing late-onset persistent
neuropsychiatric symptoms (NPS) in non-demented older adults. Few studies to date have …

The clinical and pathophysiological correlates of locus coeruleus (LC) degeneration in
Alzheimer's disease (AD) could be clarified using a method to index LC integrity in vivo …

Background: Mild behavioral impairment (MBI) and subjective cognitive decline (SCD) are
dementia risk states, and potentially represent neurobehavioral and neurocognitive …

Objective To compare the utility of the Mild Behavioral Impairment-Checklist (MBI-C) and
Neuropsychiatric Inventory Questionnaire (NPI-Q) to capture NPS in subjective cognitive …

Importance Neuropsychiatric symptoms are commonly encountered and are highly
debilitating in patients with Alzheimer disease. Understanding their underpinnings has …

Background: Machine learning (ML) is a promising technique for patient-specific prediction
of mild cognitive impairment (MCI) and dementia development. Neuropsychiatric symptoms …

Background Disease-modifying drug use necessitates better Alzheimer disease (AD)
detection. Mild cognitive impairment (MCI) leverages cognitive decline to identify the risk …